Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction

American Journal of Cardiology

Volumn 92, Issue 10, 2003, Pages 1201-1203

  Van Haelst, Paul L ^a   Liem, Anho ^b   Van Boven, Ad J ^b   Veeger, Nic J ^b   Van Veldhuisen, Dirk J ^b   Cohen Tervaert, Jan W ^b   Gans, Rijk O ^b   Zijlstra, Felix ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEOPTERIN; NITRATE; SALICYLIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISEASE MARKER; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MACROPHAGE; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; THORAX PAIN;

EID: 0242492234     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.07.031     Document Type: Article

References (11)

1. Liem A.H., van Boven A.J., Veeger N.J., Withagen A.J., Robles de Medina R.M., Tijssen J.G., van Veldhuisen D.J. Effect of fluvastatin on ischaemia following acute myocardial infarction a randomized trial . Eur Heart J. 23:2002;1931-1937.
2. Highton J., Hessian P. A solid-phase enzyme immunoassay for C-reactive protein clinical value and the effect of rheumatoid factor . J Immunol Methods. 68:1984;185-192.
3. de Winter R.J., Bholasingh R., Lijmer J.G., Koster R.W., Gorgels J.P., Schouten Y., Hoek F.J., Sanders G.T. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction. Cardiovasc Res. 42:1999;240-245.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 340:1999;115-126.
5. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
6. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 160:1984;310-316.
7. Schumacher M., Halwachs G., Tatzber F., Fruhwald F.M., Zweiker R., Watzinger N., Eber B., Wilders-Truschnig M., Esterbauer H., Klein W. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol. 30:1997;703-707.
8. Gupta S., Fredericks S., Schwartzman R.A., Holt D.W., Kaski J.C. Serum neopterin in acute coronary syndromes. Lancet. 349:1997;1252-1253.
9. Garcia-Moll X., Cole D., Zouridakis E., Kaski J.C. Increased serum neopterin a marker of coronary artery disease activity in women . Heart. 83:2000;346-350.
10. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., Schwartz D.A. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 347:2002;185-192.
11. Auer J., Berent R., Lassnig E., Weber T., Eber B. Prognostic significance of immune activation after acute coronary syndromes. J Am Coll Cardiol. 39:2002;1878.